Upstream And McGill University To Collaborate On Testing Of Potential Tropical Disease Treatments
Upstream Biosciences Inc. (OTCBB: UPBS) announced that it has entered into a collaboration with McGill University’s Institute of Parasitology in Montreal, Quebec, Canada to begin in vitro testing of the Company’s second generation of drug candidates for the potential treatment of tropical diseases leishmaniasis, trypanaosomiasis (African sleeping sickness) and malaria. Joel L.
More: continued here
Filed under: Tropical on July 16th, 2008